Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells

Nature Biotechnology

Volumn 32, Issue 8, 2014, Pages 724-726

  Andrews, Peter W ^a,b   Cavanagro, Joy ^c   Deans, Robert ^d   Feigel, Ellen ^e   Horowitz, Ed ^f   Keating, Armand ^g   Rao, Mahendra ^h,m   Turner, Marc ⁱ   Wilmut, Ian ^j   Yamanaka, Shinya ^k,l  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b Coordinator of International Stem Cell Initiative ^*  (United States)

^c Access BIO   (United States)

^d ATHERSYS INC   (United States)

^e California Institute for Regenerative Medicine   (United States)

^f International Society for Cellular Therapy   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h NATIONAL INSTITUTES OF HEALTH   (United States)

ⁱ SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^j UNIVERSITY OF EDINBURGH   (United Kingdom)

^k KYOTO UNIVERSITY   (Japan)

^l International Society for Stem Cell Research   (United States)

^m New York Stem Cell Foundation   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EMBRYONIC STEM CELL; GOOD MANUFACTURING PRACTICE; LETTER; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; BIOLOGICAL THERAPY; BIOTECHNOLOGY; CYTOLOGY; HUMAN; STANDARDS;

BIOTECHNOLOGY; CELL- AND TISSUE-BASED THERAPY; HUMANS; PLURIPOTENT STEM CELLS;

EID: 84905728674     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2973     Document Type: Letter

References (17)

1. Yamanaka, S. Cell Stem Cell 10, 678-684 (2012).
2. Rao, M.S. & Collins, F.S. Stem Cells Transl. Med. 1, 15-17 (2012).
3. Sipp, D. & Turner, L. Science 338, 1296-1297 (2012).
4. Allison, M. Nat. Biotechnol. 30, 304 (2012).
5. Ahrlund-Richter, L. et al. Cell Stem Cell 4, 20-26 (2009).
6. Carpenter, M.K. & Couture, L.A. Regen. Med. 5, 569-579 (2010).
7. Bravery, C.A. et al. Cytotherapy 15, 9-19 (2013).
8. Rawley, J. et al. BioProcess International 10, 16-22 (2012).
9. Clarke, D. Stanton J. Cytotherapy. 14, 1032-1040 (2012).
10. Lomax, G.P., Hull, S.C., Lowenthal, J., Rao, M. & Isasi, R. Stem Cells Transl. Med. 2, 727-730 (2013).
11. Lowenthal, J., Lipnick, S., Rao, M. & Hull, S.C. Stem Cells Trans. Med. 1, 409-421 (2012).
12. Magnus, D. J. Law Med. Ethics 38, 267-276 (2010).
13. Georgieva, B.P. & Love, J.M. Regen. Med. 5, 581-591 (2010).
14. Rao, M.S. Stem Cell Res. Ther. 4, 98 (2013).
15. Obasogie, O.K. & Theung, H. Stanford Technology Law Review 16, 51-78 (2012).
16. Turner, M. et al. Cell Stem Cell 13, 382-384 (2013).
17. http://www.fda.gov/internationalprograms/internationalcommunications/ embassybriefings/ucm202888.htm